Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$23.0M
-20.0% from 2023
Prescriptions
2,145
$10,711.03 per claim
Patients
410
263 prescribers
Total spending, 2024
$23.0M
$56,036.96 per patient
Medicare prescription drug plans paid $23.0M for Tecentriq in 2024, for 2,145 prescriptions and refills to 410 patients (down 20.0% from 2023). The average cost per claim was $10,711.03.
New York had the highest Medicare cost for Tecentriq in 2024: $4.0M for 373 claims, followed by California ($2.9M).
Kamal Patel, hematology-oncology in Little Rock, AR, had the highest Medicare cost for Tecentriq in 2024: 71 claims costing $758K.
Tecentriq is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kamal Patel Little Rock, AR | Hematology-Oncology | 71 | Under 11 | $758K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 45 | Under 11 | $473K |
| Manish Dhawan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 256 | 2,314 | 400 | $24.6M |
| 2023 | 260 | 2,598 | 409 | $28.7M |
| 2024 | 263 | 2,145 | 410 | $23.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 40 |
| Under 11 |
| $419K |
| Syed H Abid St Petersburg, FL | Medical Oncology | 38 | Under 11 | $394K |
| John J Graham Canfield, OH | Hematology-Oncology | 37 | Under 11 | $393K |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 37 | Under 11 | $391K |
| Dirk C Davidson Crossville, TN | Medical Oncology | 36 | Under 11 | $372K |
| Satish A Shah Gettysburg, PA | Hematology-Oncology | 34 | Under 11 | $360K |
| Andrew Briggler Little Rock, AR | Hematology-Oncology | 33 | Under 11 | $359K |
| Thomas B Sneed Little Rock, AR | Hematology-Oncology | 30 | Under 11 | $323K |
| James M Orsini Jr. Belleville, NJ | Hematology-Oncology | 30 | Under 11 | $320K |
| Jun Ma Flushing, NY | Physician Assistant | 30 | Under 11 | $309K |
| Zili He X Flushing, NY | Hematology-Oncology | 26 | Under 11 | $276K |
| Matthew M Sochat Goldsboro, NC | Hematology-Oncology | 24 | Under 11 | $276K |
| Aasim S Sehbai Anniston, AL | Medical Oncology | 19 | Under 11 | $275K |
| Yasir Alhassani Temple Terrace, FL | Hematology-Oncology | 23 | Under 11 | $253K |
| Nelson A Matos-Fernandez Santa Isabel, PR | Hematology-Oncology | 24 | Under 11 | $252K |
| Deepali Sharma Riverhead, NY | Internal Medicine | 23 | Under 11 | $247K |
| Carlos A Gadea Orlando, FL | Hematology-Oncology | 20 | Under 11 | $210K |
| Nino Aleksidze Montgomery, AL | Hematology-Oncology | 16 | Under 11 | $209K |
| Samer S Kasbari Goldsboro, NC | Hematology-Oncology | 19 | Under 11 | $206K |
| Ramsey N Asmar Brooklyn, NY | Hematology-Oncology | 19 | Under 11 | $204K |
| Sujie Tang Sherman Oaks, CA | Hematology-Oncology | 19 | Under 11 | $201K |
| Rickey C Myhand Frankfort, KY | Hematology-Oncology | 18 | Under 11 | $190K |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 19 | Under 11 | $187K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 2,145 | $23.0M |